Vladimir Zharov
Concepts (381)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Flow Cytometry | 41 | 2021 | 546 | 10.790 |
Why?
| Photoacoustic Techniques | 25 | 2021 | 86 | 8.700 |
Why?
| Neoplastic Cells, Circulating | 22 | 2021 | 93 | 6.010 |
Why?
| Molecular Imaging | 15 | 2021 | 60 | 4.730 |
Why?
| Gold | 29 | 2020 | 164 | 4.510 |
Why?
| Nanoparticles | 21 | 2020 | 173 | 4.250 |
Why?
| Lasers | 28 | 2021 | 141 | 3.990 |
Why?
| Nanotubes, Carbon | 15 | 2020 | 70 | 3.290 |
Why?
| Light | 13 | 2020 | 82 | 3.220 |
Why?
| Acoustics | 9 | 2016 | 38 | 2.800 |
Why?
| Contrast Media | 11 | 2017 | 221 | 2.560 |
Why?
| Nanotechnology | 8 | 2015 | 39 | 2.390 |
Why?
| Metal Nanoparticles | 12 | 2020 | 96 | 2.340 |
Why?
| Animals | 69 | 2022 | 14385 | 2.020 |
Why?
| Erythrocytes | 8 | 2022 | 98 | 2.010 |
Why?
| Microscopy | 10 | 2018 | 66 | 2.000 |
Why?
| Mesentery | 9 | 2011 | 36 | 1.910 |
Why?
| Temperature | 11 | 2016 | 177 | 1.890 |
Why?
| Mice, Nude | 17 | 2018 | 283 | 1.870 |
Why?
| Fluorescent Dyes | 8 | 2020 | 116 | 1.860 |
Why?
| Mice | 41 | 2022 | 6413 | 1.820 |
Why?
| Phototherapy | 11 | 2019 | 53 | 1.760 |
Why?
| Microscopy, Fluorescence | 9 | 2019 | 198 | 1.680 |
Why?
| Lymphatic Vessels | 6 | 2019 | 47 | 1.670 |
Why?
| Melanoma | 5 | 2022 | 313 | 1.590 |
Why?
| Image Cytometry | 4 | 2011 | 15 | 1.580 |
Why?
| Cell Line, Tumor | 26 | 2021 | 1550 | 1.540 |
Why?
| Thermography | 5 | 2009 | 16 | 1.450 |
Why?
| Neoplasms | 16 | 2019 | 1315 | 1.430 |
Why?
| Spectrum Analysis, Raman | 10 | 2020 | 68 | 1.420 |
Why?
| Plasmodium yoelii | 2 | 2022 | 17 | 1.410 |
Why?
| Single-Cell Analysis | 4 | 2019 | 56 | 1.390 |
Why?
| Malaria | 2 | 2022 | 37 | 1.370 |
Why?
| Hot Temperature | 10 | 2013 | 199 | 1.350 |
Why?
| Melanoma, Experimental | 3 | 2016 | 49 | 1.280 |
Why?
| Magnetite Nanoparticles | 4 | 2019 | 25 | 1.280 |
Why?
| Drug Delivery Systems | 7 | 2019 | 151 | 1.260 |
Why?
| Cell Separation | 5 | 2008 | 107 | 1.200 |
Why?
| Nanostructures | 6 | 2019 | 53 | 1.140 |
Why?
| Lymph | 6 | 2019 | 19 | 1.130 |
Why?
| Blood Volume | 2 | 2019 | 69 | 1.110 |
Why?
| Staphylococcus aureus | 4 | 2019 | 361 | 1.060 |
Why?
| Pharmaceutical Preparations | 2 | 2017 | 86 | 1.050 |
Why?
| Quantum Dots | 3 | 2017 | 18 | 1.040 |
Why?
| Laser Therapy | 4 | 2017 | 91 | 1.030 |
Why?
| Anemia, Sickle Cell | 3 | 2016 | 94 | 1.030 |
Why?
| Skin | 5 | 2020 | 469 | 1.030 |
Why?
| Photometry | 5 | 2010 | 17 | 1.020 |
Why?
| Green Fluorescent Proteins | 3 | 2019 | 110 | 1.000 |
Why?
| Spectrum Analysis | 8 | 2016 | 79 | 0.990 |
Why?
| Ultrasonic Therapy | 3 | 2017 | 40 | 0.970 |
Why?
| Breast Neoplasms | 7 | 2018 | 1248 | 0.960 |
Why?
| Fluorescence | 5 | 2018 | 53 | 0.960 |
Why?
| Blood Vessels | 3 | 2019 | 78 | 0.950 |
Why?
| Microscopy, Confocal | 2 | 2015 | 110 | 0.930 |
Why?
| Staphylococcal Infections | 2 | 2019 | 300 | 0.910 |
Why?
| Humans | 65 | 2021 | 54246 | 0.890 |
Why?
| Rats | 17 | 2019 | 3415 | 0.880 |
Why?
| Disease Models, Animal | 6 | 2021 | 1639 | 0.860 |
Why?
| Models, Theoretical | 3 | 2017 | 184 | 0.830 |
Why?
| Plant Leaves | 2 | 2011 | 49 | 0.790 |
Why?
| Drug Carriers | 3 | 2017 | 81 | 0.770 |
Why?
| Photochemotherapy | 2 | 2017 | 37 | 0.770 |
Why?
| Ultrasonography | 4 | 2020 | 480 | 0.760 |
Why?
| Skin Neoplasms | 3 | 2011 | 532 | 0.750 |
Why?
| Graphite | 2 | 2019 | 31 | 0.750 |
Why?
| Protein Engineering | 1 | 2019 | 21 | 0.720 |
Why?
| Melanins | 5 | 2021 | 30 | 0.720 |
Why?
| Nanomedicine | 5 | 2017 | 22 | 0.710 |
Why?
| Nicotine | 3 | 2005 | 207 | 0.700 |
Why?
| Apoptosis | 4 | 2018 | 1300 | 0.690 |
Why?
| Diagnostic Imaging | 4 | 2017 | 184 | 0.690 |
Why?
| Early Detection of Cancer | 4 | 2022 | 161 | 0.680 |
Why?
| Nanocomposites | 1 | 2019 | 11 | 0.680 |
Why?
| Cardiovascular Diseases | 4 | 2021 | 475 | 0.660 |
Why?
| Silicon Dioxide | 2 | 2020 | 18 | 0.660 |
Why?
| Blood Circulation | 3 | 2021 | 20 | 0.640 |
Why?
| Hemorheology | 3 | 2011 | 14 | 0.620 |
Why?
| Models, Biological | 3 | 2009 | 823 | 0.620 |
Why?
| Nanospheres | 2 | 2017 | 11 | 0.610 |
Why?
| Image Interpretation, Computer-Assisted | 6 | 2011 | 119 | 0.610 |
Why?
| Leukocytes | 3 | 2016 | 85 | 0.600 |
Why?
| Molecular Probes | 1 | 2016 | 13 | 0.590 |
Why?
| Luminescent Proteins | 2 | 2014 | 66 | 0.590 |
Why?
| Nanotubes | 7 | 2020 | 38 | 0.590 |
Why?
| Lasers, Semiconductor | 2 | 2022 | 10 | 0.580 |
Why?
| Image Enhancement | 2 | 2006 | 56 | 0.580 |
Why?
| Lasers, Solid-State | 1 | 2017 | 32 | 0.570 |
Why?
| Hemeproteins | 1 | 2016 | 5 | 0.570 |
Why?
| Parasitemia | 1 | 2016 | 5 | 0.570 |
Why?
| Embolism | 1 | 2016 | 27 | 0.570 |
Why?
| Pancreatic Neoplasms | 3 | 2020 | 234 | 0.570 |
Why?
| Imaging, Three-Dimensional | 3 | 2012 | 171 | 0.560 |
Why?
| Cell Survival | 8 | 2018 | 657 | 0.560 |
Why?
| Exosomes | 1 | 2016 | 45 | 0.560 |
Why?
| Lymphatic Metastasis | 4 | 2020 | 256 | 0.550 |
Why?
| Antineoplastic Agents | 4 | 2017 | 1300 | 0.550 |
Why?
| Magnetics | 3 | 2011 | 44 | 0.540 |
Why?
| Laser Scanning Cytometry | 3 | 2010 | 10 | 0.540 |
Why?
| Escherichia coli | 2 | 2007 | 250 | 0.530 |
Why?
| Staining and Labeling | 3 | 2013 | 106 | 0.510 |
Why?
| Blood Cells | 4 | 2012 | 58 | 0.510 |
Why?
| Plant Roots | 2 | 2011 | 37 | 0.490 |
Why?
| Optical Phenomena | 2 | 2017 | 11 | 0.480 |
Why?
| Neoplastic Stem Cells | 3 | 2020 | 103 | 0.480 |
Why?
| Hyperthermia, Induced | 4 | 2019 | 107 | 0.480 |
Why?
| Infrared Rays | 3 | 2016 | 27 | 0.480 |
Why?
| Blood Flow Velocity | 2 | 2011 | 114 | 0.470 |
Why?
| Signal Processing, Computer-Assisted | 3 | 2011 | 92 | 0.470 |
Why?
| Blood Coagulation | 2 | 2011 | 69 | 0.470 |
Why?
| Neoplasm Metastasis | 2 | 2015 | 252 | 0.460 |
Why?
| Mosquito Control | 1 | 2013 | 4 | 0.460 |
Why?
| Aedes | 1 | 2013 | 9 | 0.460 |
Why?
| Neoplasm Proteins | 2 | 2006 | 359 | 0.460 |
Why?
| Microscopy, Electron, Transmission | 5 | 2017 | 87 | 0.450 |
Why?
| Lymph Nodes | 3 | 2020 | 284 | 0.450 |
Why?
| Rats, Sprague-Dawley | 7 | 2019 | 1663 | 0.450 |
Why?
| Scattering, Radiation | 3 | 2009 | 31 | 0.440 |
Why?
| Early Diagnosis | 4 | 2016 | 96 | 0.430 |
Why?
| Models, Animal | 3 | 2010 | 255 | 0.430 |
Why?
| Drug Evaluation, Preclinical | 2 | 2017 | 158 | 0.420 |
Why?
| Carotenoids | 1 | 2012 | 46 | 0.420 |
Why?
| Equipment Design | 6 | 2017 | 318 | 0.420 |
Why?
| Reproducibility of Results | 6 | 2021 | 1304 | 0.420 |
Why?
| Xylem | 1 | 2011 | 4 | 0.420 |
Why?
| Phloem | 1 | 2011 | 4 | 0.420 |
Why?
| Silver | 3 | 2017 | 54 | 0.410 |
Why?
| Bacteremia | 1 | 2012 | 101 | 0.400 |
Why?
| KB Cells | 1 | 2010 | 5 | 0.390 |
Why?
| Cytochromes c | 1 | 2010 | 41 | 0.390 |
Why?
| Thromboembolism | 1 | 2011 | 56 | 0.390 |
Why?
| Gene Expression Regulation, Plant | 1 | 2010 | 50 | 0.390 |
Why?
| Optics and Photonics | 2 | 2018 | 13 | 0.380 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2013 | 434 | 0.380 |
Why?
| Microscopy, Video | 2 | 2006 | 18 | 0.360 |
Why?
| Cells | 1 | 2009 | 3 | 0.360 |
Why?
| Etoposide | 1 | 2009 | 85 | 0.360 |
Why?
| Time Factors | 7 | 2018 | 3212 | 0.350 |
Why?
| Spectrophotometry, Infrared | 1 | 2009 | 9 | 0.350 |
Why?
| Color | 3 | 2016 | 29 | 0.350 |
Why?
| Blood Chemical Analysis | 1 | 2009 | 34 | 0.350 |
Why?
| Adipocytes | 1 | 2010 | 129 | 0.340 |
Why?
| Microscopy, Acoustic | 1 | 2008 | 6 | 0.340 |
Why?
| Capillaries | 2 | 2007 | 58 | 0.330 |
Why?
| Photochemistry | 4 | 2010 | 21 | 0.330 |
Why?
| Receptors, Cell Surface | 3 | 2019 | 130 | 0.330 |
Why?
| Image Processing, Computer-Assisted | 3 | 2018 | 256 | 0.320 |
Why?
| Cell Culture Techniques | 2 | 2005 | 112 | 0.320 |
Why?
| Lenses | 1 | 2007 | 5 | 0.320 |
Why?
| Antibodies | 4 | 2014 | 178 | 0.310 |
Why?
| Colony Count, Microbial | 1 | 2007 | 66 | 0.310 |
Why?
| Cell Count | 3 | 2019 | 181 | 0.310 |
Why?
| Escherichia coli Infections | 1 | 2007 | 33 | 0.310 |
Why?
| Ultrasonics | 2 | 2016 | 32 | 0.310 |
Why?
| Myocardial Infarction | 1 | 2011 | 424 | 0.300 |
Why?
| Flow Injection Analysis | 1 | 2006 | 2 | 0.300 |
Why?
| Spectrophotometry | 3 | 2016 | 36 | 0.300 |
Why?
| Doxorubicin | 2 | 2019 | 259 | 0.290 |
Why?
| Particle Size | 3 | 2013 | 88 | 0.290 |
Why?
| Vinblastine | 1 | 2006 | 41 | 0.290 |
Why?
| Lymphocytes | 2 | 2005 | 168 | 0.290 |
Why?
| Lymphedema | 1 | 2007 | 43 | 0.290 |
Why?
| Mitochondria | 1 | 2010 | 489 | 0.290 |
Why?
| Mesenteric Arteries | 1 | 2006 | 45 | 0.280 |
Why?
| Neoplasm Recurrence, Local | 4 | 2021 | 644 | 0.280 |
Why?
| Stroke | 1 | 2011 | 524 | 0.270 |
Why?
| Nicotinic Agonists | 1 | 2005 | 60 | 0.270 |
Why?
| Indocyanine Green | 2 | 2019 | 39 | 0.270 |
Why?
| Antibodies, Neoplasm | 1 | 2005 | 35 | 0.270 |
Why?
| Cell Line | 6 | 2019 | 1153 | 0.260 |
Why?
| Carcinoma | 1 | 2006 | 153 | 0.260 |
Why?
| Pancreas | 1 | 2005 | 80 | 0.260 |
Why?
| K562 Cells | 1 | 2005 | 47 | 0.260 |
Why?
| Microcirculation | 1 | 2005 | 89 | 0.250 |
Why?
| Injections, Intravenous | 2 | 2017 | 148 | 0.250 |
Why?
| Anti-Bacterial Agents | 3 | 2019 | 820 | 0.250 |
Why?
| Lymphatic System | 2 | 2018 | 15 | 0.240 |
Why?
| Diffusion | 2 | 2017 | 20 | 0.240 |
Why?
| Systems Integration | 4 | 2007 | 23 | 0.230 |
Why?
| Folic Acid | 2 | 2017 | 139 | 0.230 |
Why?
| Sensitivity and Specificity | 4 | 2014 | 923 | 0.230 |
Why?
| Materials Testing | 2 | 2017 | 62 | 0.220 |
Why?
| Mice, Inbred C57BL | 3 | 2019 | 1999 | 0.220 |
Why?
| Plasmodium falciparum | 1 | 2022 | 18 | 0.220 |
Why?
| Carcinoma, Hepatocellular | 2 | 2021 | 203 | 0.220 |
Why?
| Combined Modality Therapy | 3 | 2017 | 692 | 0.210 |
Why?
| Huntington Disease | 1 | 2021 | 27 | 0.200 |
Why?
| Pharmacokinetics | 2 | 2017 | 18 | 0.200 |
Why?
| Mice, Transgenic | 2 | 2016 | 656 | 0.200 |
Why?
| Adenocarcinoma | 1 | 2005 | 428 | 0.200 |
Why?
| Administration, Cutaneous | 2 | 2017 | 63 | 0.200 |
Why?
| Rheology | 2 | 2011 | 12 | 0.200 |
Why?
| Phantoms, Imaging | 2 | 2011 | 126 | 0.190 |
Why?
| Dose-Response Relationship, Drug | 4 | 2019 | 1476 | 0.190 |
Why?
| HeLa Cells | 3 | 2009 | 291 | 0.180 |
Why?
| Stromal Cells | 1 | 2020 | 79 | 0.180 |
Why?
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 12 | 0.180 |
Why?
| Sentinel Lymph Node Biopsy | 1 | 2020 | 127 | 0.180 |
Why?
| Surgical Wound Infection | 1 | 2001 | 126 | 0.180 |
Why?
| Phagocytosis | 2 | 2017 | 51 | 0.180 |
Why?
| Muscle Cells | 1 | 2019 | 24 | 0.180 |
Why?
| Pseudomonas aeruginosa | 1 | 2019 | 86 | 0.170 |
Why?
| Staurosporine | 1 | 2018 | 14 | 0.170 |
Why?
| Meningeal Neoplasms | 1 | 2019 | 50 | 0.170 |
Why?
| Muscle Contraction | 1 | 2019 | 109 | 0.170 |
Why?
| Tomography, Optical Coherence | 1 | 2020 | 148 | 0.170 |
Why?
| Therapeutics | 1 | 2018 | 6 | 0.170 |
Why?
| Quaternary Ammonium Compounds | 1 | 1998 | 24 | 0.170 |
Why?
| Diagnostic Techniques and Procedures | 1 | 2018 | 6 | 0.170 |
Why?
| Kinetics | 2 | 2011 | 692 | 0.170 |
Why?
| Administration, Topical | 1 | 1998 | 71 | 0.170 |
Why?
| Computer Systems | 2 | 2009 | 21 | 0.170 |
Why?
| Microscopy, Phase-Contrast | 2 | 2009 | 16 | 0.160 |
Why?
| Ultrasonography, Interventional | 2 | 2017 | 146 | 0.160 |
Why?
| Female | 8 | 2021 | 28418 | 0.160 |
Why?
| Endothelium, Lymphatic | 2 | 2009 | 13 | 0.160 |
Why?
| Lymphatic Abnormalities | 1 | 2017 | 22 | 0.150 |
Why?
| Tumor Cells, Cultured | 2 | 2009 | 477 | 0.150 |
Why?
| Histocompatibility Antigens Class II | 1 | 2017 | 43 | 0.150 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 42 | 0.150 |
Why?
| Galectin 1 | 1 | 2017 | 21 | 0.150 |
Why?
| Bacterial Infections | 1 | 2018 | 105 | 0.150 |
Why?
| Biocompatible Materials | 1 | 2017 | 65 | 0.150 |
Why?
| Hemoglobin, Sickle | 1 | 2016 | 7 | 0.150 |
Why?
| Polyethylene Glycols | 1 | 2017 | 106 | 0.150 |
Why?
| Nonlinear Dynamics | 1 | 2016 | 21 | 0.150 |
Why?
| Liver Neoplasms | 1 | 2021 | 352 | 0.150 |
Why?
| Cells, Cultured | 3 | 2007 | 1737 | 0.140 |
Why?
| Caenorhabditis elegans | 2 | 2021 | 146 | 0.140 |
Why?
| Schizonts | 1 | 2016 | 4 | 0.140 |
Why?
| Photochemical Processes | 2 | 2014 | 10 | 0.140 |
Why?
| Dendritic Cells | 1 | 2017 | 142 | 0.140 |
Why?
| Ear | 1 | 2016 | 21 | 0.140 |
Why?
| Ampicillin | 1 | 2016 | 6 | 0.140 |
Why?
| Transducers | 1 | 2016 | 20 | 0.140 |
Why?
| Host-Parasite Interactions | 1 | 2016 | 20 | 0.140 |
Why?
| Equipment Failure Analysis | 2 | 2006 | 49 | 0.140 |
Why?
| Computers, Handheld | 1 | 2016 | 27 | 0.140 |
Why?
| Genes, Reporter | 1 | 2016 | 98 | 0.140 |
Why?
| Surface Plasmon Resonance | 3 | 2017 | 25 | 0.140 |
Why?
| Brain Neoplasms | 1 | 2019 | 284 | 0.140 |
Why?
| Drug Compounding | 1 | 2015 | 28 | 0.130 |
Why?
| Workflow | 1 | 2015 | 57 | 0.130 |
Why?
| Mammography | 1 | 2015 | 95 | 0.130 |
Why?
| Biological Transport | 1 | 2015 | 195 | 0.130 |
Why?
| Blood Platelets | 2 | 2021 | 269 | 0.130 |
Why?
| Male | 7 | 2021 | 27312 | 0.130 |
Why?
| Cell Tracking | 1 | 2014 | 5 | 0.120 |
Why?
| Necrosis | 2 | 2005 | 208 | 0.120 |
Why?
| Magnetic Phenomena | 1 | 2013 | 7 | 0.120 |
Why?
| Neoplasm Staging | 1 | 2016 | 806 | 0.120 |
Why?
| Cerebrospinal Fluid | 1 | 2013 | 35 | 0.110 |
Why?
| Algorithms | 2 | 2010 | 697 | 0.110 |
Why?
| Staphylococcal Protein A | 1 | 2012 | 7 | 0.110 |
Why?
| Biopsy | 1 | 2015 | 692 | 0.110 |
Why?
| Lipoproteins | 1 | 2012 | 45 | 0.110 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2013 | 204 | 0.110 |
Why?
| Complementary Therapies | 1 | 2012 | 31 | 0.110 |
Why?
| Intracellular Space | 1 | 2012 | 31 | 0.110 |
Why?
| Radiation Dosage | 1 | 2013 | 170 | 0.100 |
Why?
| Gentian Violet | 1 | 2011 | 6 | 0.100 |
Why?
| Erythrocyte Deformability | 1 | 2011 | 2 | 0.100 |
Why?
| Optical Fibers | 1 | 2011 | 10 | 0.100 |
Why?
| Trypan Blue | 1 | 2011 | 10 | 0.100 |
Why?
| Blood Viscosity | 1 | 2011 | 4 | 0.100 |
Why?
| Erythrocyte Aggregation | 1 | 2011 | 4 | 0.100 |
Why?
| Succinimides | 1 | 2011 | 8 | 0.100 |
Why?
| Arterioles | 1 | 2011 | 35 | 0.100 |
Why?
| Fluoresceins | 1 | 2011 | 16 | 0.100 |
Why?
| Hematologic Tests | 1 | 2011 | 11 | 0.100 |
Why?
| Methylene Blue | 1 | 2011 | 12 | 0.100 |
Why?
| Hematocrit | 1 | 2011 | 51 | 0.100 |
Why?
| Splanchnic Circulation | 1 | 2011 | 43 | 0.100 |
Why?
| Carotid Arteries | 1 | 2011 | 82 | 0.100 |
Why?
| Platelet Aggregation | 1 | 2011 | 82 | 0.100 |
Why?
| Aquaporin 2 | 1 | 2010 | 7 | 0.100 |
Why?
| Blood Loss, Surgical | 1 | 2011 | 79 | 0.100 |
Why?
| Hemoglobins | 1 | 2011 | 126 | 0.100 |
Why?
| Immunoconjugates | 1 | 2011 | 38 | 0.100 |
Why?
| Bacteria | 1 | 2013 | 258 | 0.100 |
Why?
| Biopsy, Needle | 1 | 2011 | 195 | 0.100 |
Why?
| Mastectomy, Segmental | 1 | 2011 | 95 | 0.100 |
Why?
| Neoplasm Transplantation | 1 | 2010 | 94 | 0.100 |
Why?
| Microarray Analysis | 1 | 2010 | 84 | 0.100 |
Why?
| Carcinoma, Ductal, Breast | 1 | 2011 | 96 | 0.090 |
Why?
| Chylomicrons | 1 | 2010 | 4 | 0.090 |
Why?
| Spectroscopy, Near-Infrared | 1 | 2010 | 62 | 0.090 |
Why?
| Oscillometry | 1 | 2010 | 9 | 0.090 |
Why?
| Neovascularization, Pathologic | 1 | 2011 | 168 | 0.090 |
Why?
| Plant Oils | 1 | 2010 | 18 | 0.090 |
Why?
| Survival Rate | 1 | 2013 | 951 | 0.090 |
Why?
| Folate Receptors, GPI-Anchored | 1 | 2009 | 7 | 0.090 |
Why?
| Ablation Techniques | 1 | 2009 | 25 | 0.090 |
Why?
| Water | 1 | 2010 | 102 | 0.090 |
Why?
| Lymphography | 1 | 2009 | 9 | 0.090 |
Why?
| Extracellular Space | 1 | 2009 | 43 | 0.090 |
Why?
| Catheter Ablation | 1 | 2011 | 131 | 0.090 |
Why?
| Feasibility Studies | 2 | 2011 | 398 | 0.090 |
Why?
| Molecular Mimicry | 1 | 2009 | 64 | 0.090 |
Why?
| Drug Synergism | 1 | 2009 | 171 | 0.090 |
Why?
| Polymerase Chain Reaction | 1 | 2010 | 531 | 0.090 |
Why?
| Cytoplasm | 1 | 2009 | 108 | 0.090 |
Why?
| Cell Death | 1 | 2009 | 223 | 0.080 |
Why?
| Genetic Therapy | 2 | 2006 | 121 | 0.080 |
Why?
| Swine | 2 | 2001 | 431 | 0.080 |
Why?
| Mice, Inbred BALB C | 2 | 2021 | 368 | 0.080 |
Why?
| Neoplasms, Experimental | 1 | 2008 | 115 | 0.080 |
Why?
| Refractometry | 1 | 2007 | 7 | 0.080 |
Why?
| Blood Coagulation Tests | 1 | 2007 | 23 | 0.080 |
Why?
| Carrier Proteins | 1 | 2009 | 359 | 0.080 |
Why?
| Magnetic Resonance Imaging | 2 | 2011 | 1604 | 0.080 |
Why?
| Molecular Conformation | 1 | 2006 | 73 | 0.070 |
Why?
| Virology | 1 | 2006 | 9 | 0.070 |
Why?
| Oxidative Stress | 1 | 2012 | 958 | 0.070 |
Why?
| Adenoviridae | 1 | 2006 | 58 | 0.070 |
Why?
| Microscopy, Electron | 1 | 2005 | 97 | 0.070 |
Why?
| Genetic Vectors | 1 | 2006 | 139 | 0.070 |
Why?
| Metals | 1 | 2005 | 44 | 0.070 |
Why?
| Metabolic Clearance Rate | 1 | 2005 | 75 | 0.070 |
Why?
| Microspectrophotometry | 1 | 2005 | 1 | 0.070 |
Why?
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 866 | 0.070 |
Why?
| Rats, Inbred F344 | 1 | 2005 | 209 | 0.070 |
Why?
| Protein Transport | 1 | 2005 | 195 | 0.060 |
Why?
| Cluster Analysis | 1 | 2005 | 249 | 0.060 |
Why?
| Video Recording | 1 | 2005 | 90 | 0.060 |
Why?
| Computer Simulation | 1 | 2005 | 332 | 0.060 |
Why?
| Varicose Veins | 1 | 2004 | 18 | 0.060 |
Why?
| Forearm | 1 | 2004 | 41 | 0.060 |
Why?
| Veins | 1 | 2004 | 74 | 0.060 |
Why?
| Photobiology | 1 | 2002 | 2 | 0.060 |
Why?
| Biophysics | 1 | 2002 | 20 | 0.050 |
Why?
| Biophysical Phenomena | 1 | 2002 | 20 | 0.050 |
Why?
| Liposomes | 1 | 2002 | 53 | 0.050 |
Why?
| Prognosis | 2 | 2021 | 2118 | 0.050 |
Why?
| Microwaves | 1 | 2021 | 12 | 0.050 |
Why?
| Injections, Jet | 1 | 2001 | 1 | 0.050 |
Why?
| Phonophoresis | 1 | 2001 | 1 | 0.050 |
Why?
| Iontophoresis | 1 | 2001 | 15 | 0.050 |
Why?
| Chemoembolization, Therapeutic | 1 | 2021 | 12 | 0.050 |
Why?
| Macrophage Activation | 1 | 2001 | 29 | 0.050 |
Why?
| Reference Standards | 1 | 2021 | 63 | 0.050 |
Why?
| Microspheres | 1 | 2020 | 34 | 0.050 |
Why?
| Recombinant Fusion Proteins | 1 | 2021 | 206 | 0.050 |
Why?
| Photosensitizing Agents | 1 | 2001 | 24 | 0.050 |
Why?
| Anti-Infective Agents, Local | 1 | 2001 | 24 | 0.050 |
Why?
| Gram-Negative Bacteria | 1 | 2001 | 37 | 0.050 |
Why?
| Pancreatic Stellate Cells | 1 | 2020 | 3 | 0.050 |
Why?
| Spheroids, Cellular | 1 | 2020 | 26 | 0.050 |
Why?
| Optical Imaging | 1 | 2020 | 30 | 0.050 |
Why?
| Peptides | 1 | 2021 | 276 | 0.050 |
Why?
| Rabbits | 1 | 2001 | 425 | 0.050 |
Why?
| Burns | 1 | 2002 | 170 | 0.040 |
Why?
| Organ Culture Techniques | 1 | 2019 | 53 | 0.040 |
Why?
| Quartz Crystal Microbalance Techniques | 1 | 2019 | 3 | 0.040 |
Why?
| Solutions | 1 | 1998 | 29 | 0.040 |
Why?
| Antibiotics, Antineoplastic | 1 | 2019 | 85 | 0.040 |
Why?
| Injections, Subcutaneous | 1 | 1998 | 58 | 0.040 |
Why?
| Tumor Microenvironment | 1 | 2020 | 209 | 0.040 |
Why?
| Coloring Agents | 1 | 1998 | 84 | 0.040 |
Why?
| Treatment Outcome | 1 | 2009 | 5604 | 0.040 |
Why?
| Coated Materials, Biocompatible | 1 | 2017 | 40 | 0.040 |
Why?
| Wounds and Injuries | 1 | 2001 | 321 | 0.040 |
Why?
| Young Adult | 2 | 2021 | 4308 | 0.040 |
Why?
| Molecular Targeted Therapy | 1 | 2017 | 128 | 0.040 |
Why?
| Biofilms | 1 | 2018 | 200 | 0.030 |
Why?
| Cell Differentiation | 1 | 2017 | 720 | 0.030 |
Why?
| MCF-7 Cells | 1 | 2014 | 79 | 0.030 |
Why?
| Mammary Neoplasms, Animal | 1 | 2013 | 38 | 0.030 |
Why?
| Cell Proliferation | 1 | 2017 | 1096 | 0.030 |
Why?
| Macrophages | 1 | 2016 | 405 | 0.030 |
Why?
| Aged | 2 | 2021 | 10041 | 0.030 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 562 | 0.030 |
Why?
| Vacuum | 1 | 2011 | 14 | 0.030 |
Why?
| Middle Aged | 2 | 2021 | 13070 | 0.030 |
Why?
| Adult | 2 | 2021 | 14182 | 0.020 |
Why?
| Pilot Projects | 1 | 2011 | 808 | 0.020 |
Why?
| Gene Targeting | 1 | 2006 | 32 | 0.020 |
Why?
| Binding Sites | 1 | 2006 | 440 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2011 | 3429 | 0.010 |
Why?
| Risk Factors | 1 | 2011 | 3930 | 0.010 |
Why?
| Adolescent | 1 | 2011 | 6885 | 0.010 |
Why?
|
|
Zharov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|